GranuFlo Lawsuit News: New Motion Seeks to Have Massachusetts Law Applied to Claims Filed on Behalf of Mississippi Residents, Bernstein Liebhard LLP Reports

Share Article

The Firm is representing numerous GranuFlo lawsuit plaintiffs who were allegedly harmed by dialysis concentrates included in the 2012 GranuFlo and NaturaLyte recall.

Free Case Review
Our Firm is representing numerous GranuFlo recall clients who have claims pending in this proceeding. We are monitoring developments very closely.

GranuFlo lawsuits (http://www.injurybeacon.com/granuflo-dialysis/lawsuit/) filed on behalf of individuals who were allegedly harmed by dialysis concentrates included in the 2012 GranuFlo and NaturaLyte recall continue to move forward in a federal multidistrict litigation now underway in U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP reports. According to a Motion filed on October 3, 2014, 127 plaintiffs who are residents of Mississippi have asked the Court not to apply the law of their home state to their cases. Fresenius Medical Care has argued that the claims were filed outside of Mississippi’s three-year statute of limitations. But the plaintiffs assert, among other things, that Massachusetts law should apply to their lawsuits because they were originally filed in that jurisdiction. (In re Fresenius GranuFlo/Naturalyte Dialysate Litigation, MDL No. 2428)

“Our Firm is representing numerous GranuFlo recall clients who have claims pending in this proceeding. We are monitoring developments very closely,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free GranuFlo lawsuit evaluations to dialysis patients who allegedly suffered cardiac arrest, heart attacks, stroke, sudden cardiac death or other side effects within 72 hours of a dialysis treatment involving the use of GranuFlo or NaturaLyte dialysis drugs.

GranuFlo and NaturaLyte Litigation
Both GranuFlo and NaturaLyte are manufactured by Fresenius Medical Care, and are administered to kidney failure patients to remove toxins from the blood during dialysis treatments. Court documents indicate that at least 2,089 GranuFlo lawsuits have been filed in the District of Massachusetts on behalf of dialysis patients who allegedly experienced serious cardiovascular events due to the administration of the two drugs. All of the lawsuits pending in the federal litigation similarly allege that Fresenius failed to provide adequate warnings regarding the risks associated with GranuFlo and NaturaLyte, and that the company continued to aggressively market the concentrates even after those dangers became known.

In addition to the cases pending in the District of Massachusetts, additional GranuFlo and NaturaLyte lawsuits have been consolidated on the state level in the Massachusetts’ Middlesex County Superior Court. Filings indicate that more than 3,900 claims are pending in that proceeding. (In re: Consolidated Fresenius Cases, No. MICV2013-03400-O).

In March 2012, Fresenius issued an Urgent Product Notification for GranuFlo and NaturaLyte that warned of dosage issues that could cause dialysis patients to suffer serious and catastrophic heart side effects. The U.S. Food & Drug Administration (FDA) ultimately granted Class I recall status to the Urgent Product Notification, which indicates the products posed a risk of serious injury and death.

Dialysis patients who were allegedly harmed by GranuFlo or NaturaLyte may be entitled to take legal action against Fresenius Medical Care. To learn more about filing a GranuFlo lawsuit, please visit Bernstein Liebhard LLP’s website, or the Firm’s Facebook page: https://www.facebook.com/granuflolawsuit. For additional information, and to arrange for a free case review, please call 800-511-5092.

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
800-511-5092

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Contact Information:

Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info(at)consumerinjurylawyers(dot)com
http://www.injurybeacon.com/
https://plus.google.com/115936073311125306742?rel=author

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website